LOXAPAC 100 mg, film-coated tablet 30 tablets, CIP 3400958486111
Active ingredients: Loxapine, Loxapine succinate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400958486111orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOXAPAC 100 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium prédécoupées de 30 comprimé(s)
- Marketing authorisation holder
- CNX THERAPEUTICS FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Oct 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69893582CIP75848611CIP133400958486111Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SUCCINATE DE LOXAPINEcomprimé | 136 mg · un comprimé | SA |
| LOXAPINE BASEcomprimé | 100 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.